| Lactose (India) Ltd | 136 Cr. | 108 | 247/84.3 | 30.0 | 49.6 | 0.00 % | 12.9 % | 9.69 % | 10.0 |
| MPS Pharmaa Ltd | 3.52 Cr. | 1.84 | 4.33/1.82 | | 0.57 | 0.00 % | 9.79 % | 59.0 % | 10.0 |
| Gujarat Themis Biosyn Ltd | 4,902 Cr. | 450 | 479/192 | 102 | 24.3 | 0.15 % | 27.3 % | 21.7 % | 1.00 |
| Gujarat Terce Laboratories Ltd | 33.4 Cr. | 45.0 | 92.2/37.2 | | 10.6 | 0.00 % | 41.4 % | 14.6 % | 10.0 |
| Gujarat Inject (Kerala) Ltd | 37.4 Cr. | 25.6 | 29.1/17.0 | 89.2 | 6.93 | 0.00 % | 13.5 % | 11.0 % | 10.0 |
| Godavari Drugs Ltd | 63.2 Cr. | 84.0 | 134/78.3 | 16.7 | 57.6 | 0.00 % | 10.1 % | 10.6 % | 10.0 |
| Glenmark Life Sciences Ltd | 53,092 Cr. | 1,881 | 2,286/1,275 | 39.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Gennex Laboratories Ltd | 356 Cr. | 15.7 | 19.9/10.8 | 21.6 | 8.21 | 0.00 % | 13.0 % | 10.2 % | 1.00 |
| Ganga Pharmaceuticals Ltd | 7.06 Cr. | 14.6 | 19.2/9.25 | 88.2 | 14.0 | 0.00 % | 3.18 % | 1.13 % | 10.0 |
| Fredun Pharmaceuticals Ltd | 804 Cr. | 1,703 | 1,785/635 | 27.8 | 334 | 0.04 % | 18.9 % | 15.8 % | 10.0 |
| Fervent Synergies Ltd | 111 Cr. | 22.3 | 32.0/15.0 | 30.4 | 10.8 | 0.00 % | 7.47 % | 7.47 % | 10.0 |
| Fermenta Biotech Ltd | 859 Cr. | 292 | 449/219 | 7.67 | 133 | 0.86 % | 23.0 % | 24.9 % | 5.00 |
| Fabino Enterprises Ltd | 4.83 Cr. | 23.0 | 39.0/22.8 | 37.2 | 20.4 | 0.00 % | 7.16 % | 3.08 % | 10.0 |
| Evoq Remedies Ltd | 10.2 Cr. | 4.11 | 9.28/2.11 | 5.82 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Everest Organics Ltd | 396 Cr. | 408 | 477/114 | 59.8 | 74.7 | 0.00 % | 1.76 % | 2.23 % | 10.0 |
| Entero Healthcare Solutions Ltd | 4,978 Cr. | 1,147 | 1,565/1,038 | 45.0 | 396 | 0.00 % | 8.71 % | 5.63 % | 10.0 |
| Murae Organisor Ltd | 65.4 Cr. | 0.32 | 1.24/0.26 | 4.30 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Dipna Pharmachem Ltd | 45.9 Cr. | 19.1 | 26.3/6.54 | 47.4 | 16.0 | 0.00 % | 6.64 % | 2.55 % | 10.0 |
| Decipher Labs Ltd | 9.45 Cr. | 9.36 | 17.2/9.00 | | 22.6 | 0.00 % | 4.67 % | 1.16 % | 10.0 |
| Coral Laboratories Ltd | 178 Cr. | 500 | 889/443 | 9.66 | 563 | 0.30 % | 17.4 % | 13.1 % | 10.0 |
| Concord Drugs Ltd | 86.6 Cr. | 86.6 | 92.5/26.1 | 222 | 34.1 | 0.00 % | 4.73 % | 0.88 % | 10.0 |
| Concord Biotech Ltd | 15,265 Cr. | 1,459 | 2,452/1,345 | 42.7 | 173 | 0.73 % | 28.4 % | 21.4 % | 1.00 |
| Colinz Laboratories Ltd | 19.1 Cr. | 41.8 | 88.7/36.1 | 41.5 | 21.6 | 0.00 % | 6.72 % | 5.43 % | 10.0 |
| Cian Healthcare Ltd | 17.4 Cr. | 6.95 | 7.66/2.97 | | 15.8 | 0.00 % | 5.22 % | 0.43 % | 10.0 |
| Chemo Pharma Laboratories Ltd | 18.8 Cr. | 125 | 154/63.0 | | 87.6 | 0.00 % | 5.17 % | 3.47 % | 10.0 |
| Checkpoint Trends Ltd | 43.7 Cr. | 79.9 | 79.9/9.41 | 30.1 | 1.02 | 0.00 % | 16.5 % | 9.17 % | 10.0 |
| Chandra Bhagat Pharma Ltd | 30.2 Cr. | 40.0 | 80.0/0.00 | 42.5 | 39.7 | 0.00 % | 6.00 % | 2.41 % | 10.0 |
| Brawn Biotech Ltd | 6.64 Cr. | 22.1 | 26.0/15.5 | | 11.2 | 0.00 % | 42.5 % | 41.3 % | 10.0 |
| Blue Jet Healthcare Ltd | 10,077 Cr. | 581 | 1,028/492 | 28.6 | 72.4 | 0.21 % | 39.8 % | 30.2 % | 2.00 |
| Bharat Immunological & Biological Corporation Ltd | 88.4 Cr. | 20.5 | 35.9/19.0 | | 18.2 | 0.00 % | 9.27 % | 17.7 % | 10.0 |
| Beryl Drugs Ltd | 12.2 Cr. | 24.1 | 43.7/17.4 | 53.1 | 18.7 | 0.00 % | 10.2 % | 6.30 % | 10.0 |
| Mankind Pharma Ltd | 93,033 Cr. | 2,257 | 3,055/2,115 | 55.8 | 376 | 0.04 % | 15.0 % | 13.9 % | 1.00 |
| BDH Industries Ltd | 261 Cr. | 453 | 524/241 | 26.8 | 123 | 0.99 % | 17.8 % | 14.2 % | 10.0 |
| Bacil Pharma Ltd | 42.7 Cr. | 29.8 | 62.6/26.7 | 38.5 | 17.7 | 0.00 % | 0.97 % | 0.98 % | 10.0 |
| Aurobindo Pharma Ltd | 70,639 Cr. | 1,210 | 1,365/994 | 20.6 | 598 | 0.33 % | 14.2 % | 11.1 % | 1.00 |
| Auro Laboratories Ltd | 137 Cr. | 219 | 303/159 | 130 | 69.9 | 0.00 % | 3.85 % | 4.33 % | 10.0 |
| Anuh Pharma Ltd | 819 Cr. | 82.2 | 123/74.0 | 21.2 | 32.6 | 1.82 % | 17.2 % | 13.4 % | 5.00 |
| ANG Lifesciences India Ltd | 38.8 Cr. | 29.8 | 50.0/21.0 | | 51.2 | 0.00 % | 3.54 % | 13.8 % | 10.0 |
| Acutaas Chemicals Ltd | 13,785 Cr. | 1,682 | 1,868/919 | 61.6 | 160 | 0.09 % | 19.9 % | 16.0 % | 5.00 |
| Amerise Biosciences Ltd | 3.96 Cr. | 0.60 | 1.45/0.55 | 99.0 | 0.81 | 0.00 % | 0.19 % | 0.19 % | 1.00 |
| Ambalal Sarabhai Enterprises Ltd | 241 Cr. | 31.5 | 68.0/30.0 | 15.4 | 19.2 | 0.00 % | 9.12 % | 6.25 % | 10.0 |
| Adline Chem Lab Ltd | 7.19 Cr. | 12.3 | 23.8/9.40 | | 2.75 | 0.00 % | % | % | 10.0 |
| Achyut Healthcare Ltd | 131 Cr. | 5.57 | 6.57/2.82 | 305 | 1.33 | 0.00 % | 2.26 % | 1.77 % | 1.00 |
| Abbott India Ltd | 62,852 Cr. | 29,570 | 37,000/25,260 | 41.6 | 1,888 | 1.61 % | 46.2 % | 35.7 % | 10.0 |
| Aarti Pharmalabs Ltd | 6,767 Cr. | 747 | 972/550 | 28.2 | 226 | 0.67 % | 17.4 % | 14.5 % | 5.00 |
| Aarey Drugs & Pharmaceuticals Ltd | 280 Cr. | 96.9 | 100/31.3 | 67.2 | 48.8 | 0.00 % | 6.38 % | 2.96 % | 10.0 |
| Zota Health Care Ltd | 4,671 Cr. | 1,540 | 1,628/535 | | 104 | 0.06 % | 17.0 % | 36.0 % | 10.0 |
| Wockhardt Ltd | 21,870 Cr. | 1,347 | 1,870/1,110 | 399 | 281 | 0.00 % | 3.75 % | 1.22 % | 5.00 |
| Wanbury Ltd | 870 Cr. | 249 | 330/154 | 20.2 | 18.1 | 0.00 % | 36.7 % | 76.5 % | 10.0 |
| Vivimed Labs Ltd | 41.0 Cr. | 4.95 | / | | 4.24 | 0.00 % | 8.10 % | % | 2.00 |
| Venus Remedies Ltd | 754 Cr. | 564 | 581/270 | 11.9 | 445 | 0.00 % | 11.1 % | 7.16 % | 10.0 |
| Unichem Laboratories Ltd | 3,296 Cr. | 470 | 924/438 | 22.6 | 346 | 0.00 % | 6.24 % | 5.59 % | 2.00 |
| TTK Healthcare Ltd | 1,603 Cr. | 1,134 | 1,595/991 | 22.7 | 768 | 0.88 % | 9.26 % | 6.89 % | 10.0 |
| Torrent Pharmaceuticals Ltd | 1,29,553 Cr. | 3,826 | 3,882/2,886 | 59.8 | 250 | 0.84 % | 27.0 % | 26.5 % | 5.00 |
| Themis Medicare Ltd | 1,096 Cr. | 119 | 317/98.0 | | 41.3 | 0.42 % | 10.4 % | 7.65 % | 1.00 |
| Syncom Formulations (India) Ltd | 1,562 Cr. | 16.7 | 24.0/14.1 | 24.9 | 4.00 | 0.00 % | 18.6 % | 15.5 % | 1.00 |
| Cohance Lifesciences Ltd | 24,080 Cr. | 629 | 1,360/621 | 70.1 | 99.0 | 0.00 % | 14.9 % | 12.7 % | 1.00 |
| Suven Life Sciences Ltd | 4,159 Cr. | 183 | 303/102 | | 12.4 | 0.00 % | 87.0 % | 87.2 % | 1.00 |
| Sun Pharmaceuticals Industries Ltd | 4,16,921 Cr. | 1,737 | 1,910/1,547 | 36.1 | 324 | 0.92 % | 20.2 % | 16.9 % | 1.00 |
| Solara Active Pharma Sciences Ltd | 2,550 Cr. | 571 | 886/441 | 398 | 347 | 0.00 % | 6.01 % | 0.05 % | 10.0 |
| SMS Pharmaceuticals Ltd | 2,718 Cr. | 290 | 329/175 | 33.5 | 81.2 | 0.14 % | 12.2 % | 11.0 % | 1.00 |
| SMS Lifesciences India Ltd | 387 Cr. | 1,262 | 1,680/956 | 20.7 | 683 | 0.12 % | 11.8 % | 10.8 % | 10.0 |
| Shilpa Medicare Ltd | 7,642 Cr. | 390 | 502/265 | 49.4 | 125 | 0.13 % | 7.82 % | 4.21 % | 1.00 |
| Sequent Scientific Ltd | 5,738 Cr. | 228 | 242/111 | 190 | 28.1 | 0.00 % | 8.47 % | 3.21 % | 2.00 |
| Sanofi India Ltd | 10,566 Cr. | 4,586 | 6,718/4,146 | 28.6 | 340 | 2.55 % | 49.2 % | 47.2 % | 10.0 |
| RPG Life Sciences Ltd | 3,870 Cr. | 2,334 | 2,725/1,772 | 34.7 | 335 | 0.86 % | 32.8 % | 25.5 % | 8.00 |
| Procter & Gamble Health Ltd | 9,719 Cr. | 5,854 | 6,739/4,904 | 31.7 | 373 | 2.14 % | 47.8 % | 36.4 % | 10.0 |
| Pharmaids Pharmaceuticals Ltd | 162 Cr. | 45.8 | 85.0/42.0 | | 14.7 | 0.00 % | 17.4 % | 16.3 % | 10.0 |
| Pfizer Ltd | 23,052 Cr. | 5,044 | 5,993/3,701 | 32.6 | 841 | 0.69 % | 21.6 % | 16.4 % | 10.0 |
| Par Drugs & Chemicals Ltd | 121 Cr. | 98.7 | 348/81.0 | 8.58 | 80.4 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Panacea Biotec Ltd | 2,484 Cr. | 405 | 582/281 | | 136 | 0.00 % | 4.57 % | 4.92 % | 1.00 |
| Ortin Laboratories Ltd | 16.4 Cr. | 20.1 | 26.4/16.2 | | 3.47 | 0.00 % | 60.2 % | 118 % | 10.0 |
| Orchid Pharma Ltd | 4,071 Cr. | 798 | 1,998/604 | 77.9 | 251 | 0.00 % | 8.07 % | 8.21 % | 10.0 |
| Neuland Laboratories Ltd | 22,076 Cr. | 17,223 | 19,748/10,060 | 113 | 1,263 | 0.07 % | 18.7 % | 14.8 % | 10.0 |
| Nectar Lifescience Ltd | 352 Cr. | 15.7 | 44.9/13.0 | | 42.6 | 0.00 % | 5.36 % | 11.2 % | 1.00 |
| Natco Pharma Ltd | 14,782 Cr. | 826 | 1,505/660 | 8.71 | 425 | 0.73 % | 32.8 % | 28.0 % | 2.00 |
| Morepen Laboratories Ltd | 2,549 Cr. | 46.6 | 91.7/41.7 | 27.5 | 21.1 | 0.43 % | 15.1 % | 11.8 % | 2.00 |
| Marksans Pharma Ltd | 8,712 Cr. | 192 | 359/162 | 24.8 | 59.3 | 0.42 % | 20.0 % | 16.8 % | 1.00 |
| Mangalam Drugs and Organics Ltd | 97.4 Cr. | 61.6 | 130/58.6 | | 93.9 | 0.00 % | 8.03 % | 4.71 % | 10.0 |
| Lyka Labs Ltd | 319 Cr. | 89.5 | 177/86.1 | 157 | 28.3 | 0.00 % | 9.91 % | 9.31 % | 10.0 |
| Lupin Ltd | 93,942 Cr. | 2,057 | 2,403/1,774 | 21.7 | 430 | 0.59 % | 21.3 % | 20.6 % | 2.00 |
| Lincoln Pharmaceuticals Ltd | 1,022 Cr. | 510 | 980/490 | 12.8 | 357 | 0.36 % | 17.3 % | 12.8 % | 10.0 |
| Laurus Labs Ltd | 54,207 Cr. | 1,004 | 1,025/475 | 79.4 | 91.1 | 0.12 % | 9.47 % | 7.75 % | 2.00 |
| Kwality Pharmaceuticals Ltd | 1,024 Cr. | 987 | 1,235/596 | 20.9 | 281 | 0.00 % | 18.2 % | 16.2 % | 10.0 |
| Krebs Biochemicals & Industries Ltd | 147 Cr. | 68.0 | 129/63.6 | | 73.2 | 0.00 % | 30.1 % | % | 10.0 |
| Kopran Ltd | 686 Cr. | 142 | 236/142 | 38.9 | 104 | 2.11 % | 9.75 % | 7.64 % | 10.0 |
| Kilitch Drugs (India) Ltd | 643 Cr. | 368 | 500/265 | 22.9 | 116 | 0.00 % | 15.7 % | 12.6 % | 10.0 |
| Jubilant Pharmova Ltd | 17,872 Cr. | 1,122 | 1,265/802 | 36.0 | 414 | 0.44 % | 9.54 % | 9.55 % | 1.00 |
| J B Chemicals & Pharmaceuticals Ltd | 28,512 Cr. | 1,821 | 1,952/1,303 | 39.7 | 243 | 0.85 % | 25.8 % | 20.1 % | 1.00 |
| Jagsonpal Pharmaceuticals Ltd | 1,428 Cr. | 214 | 328/193 | 32.6 | 38.0 | 1.17 % | 23.0 % | 18.6 % | 2.00 |
| Ipca Laboratories Ltd | 33,135 Cr. | 1,306 | 1,758/1,168 | 33.5 | 293 | 0.31 % | 14.7 % | 12.8 % | 1.00 |
| IOL Chemicals & Pharmaceuticals Ltd | 2,852 Cr. | 97.2 | 127/57.5 | 24.6 | 59.7 | 0.83 % | 8.86 % | 6.13 % | 2.00 |
| Ind-Swift Ltd | 85.4 Cr. | 15.8 | 34.7/12.0 | 10.9 | 74.2 | 0.00 % | 11.9 % | % | 2.00 |
| Ind-Swift Laboratories Ltd | 839 Cr. | 103 | 124/67.2 | 38.0 | 194 | 0.00 % | 0.78 % | 0.18 % | 10.0 |
| Indoco Remedies Ltd | 2,492 Cr. | 270 | 355/190 | | 106 | 0.07 % | 0.49 % | 7.02 % | 2.00 |
| Hikal Ltd | 2,964 Cr. | 240 | 465/229 | 293 | 96.9 | 0.58 % | 9.85 % | 7.38 % | 2.00 |
| Hester Biosciences Ltd | 1,453 Cr. | 1,708 | 2,768/1,243 | 33.1 | 397 | 0.41 % | 9.71 % | 9.18 % | 10.0 |
| Gufic BioSciences Ltd | 3,255 Cr. | 325 | 498/285 | 53.2 | 60.0 | 0.03 % | 13.2 % | 12.3 % | 1.00 |
| Granules India Ltd | 13,500 Cr. | 556 | 628/412 | 26.4 | 153 | 0.27 % | 15.1 % | 13.9 % | 1.00 |
| Glenmark Pharmaceuticals Ltd | 53,071 Cr. | 1,881 | 2,286/1,275 | 39.8 | 314 | 0.13 % | 19.4 % | 15.8 % | 1.00 |
| Glaxosmithkline Pharmaceuticals Ltd | 42,258 Cr. | 2,494 | 3,516/1,921 | 44.3 | 101 | 1.68 % | 63.2 % | 46.9 % | 10.0 |
| Gland Pharma Ltd | 30,137 Cr. | 1,829 | 2,131/1,200 | 26.1 | 610 | 0.98 % | 15.8 % | 11.6 % | 1.00 |
| FDC Ltd | 6,679 Cr. | 410 | 530/359 | 29.6 | 149 | 1.22 % | 15.9 % | 11.8 % | 1.00 |
| ERIS Lifesciences Ltd | 20,679 Cr. | 1,518 | 1,910/1,097 | 49.7 | 227 | 0.48 % | 12.2 % | 12.9 % | 1.00 |
| Dr Reddys Laboratories Ltd | 1,03,066 Cr. | 1,235 | 1,406/1,020 | 17.9 | 432 | 0.65 % | 22.7 % | 18.0 % | 1.00 |
| Dishman Carbogen Amcis Ltd | 3,856 Cr. | 246 | 322/178 | 25.8 | 406 | 0.00 % | 2.42 % | 0.32 % | 2.00 |
| Cipla Ltd | 1,23,250 Cr. | 1,526 | 1,673/1,310 | 22.6 | 408 | 0.85 % | 22.7 % | 17.8 % | 2.00 |
| Caplin Point Laboratories Ltd | 14,719 Cr. | 1,936 | 2,641/1,551 | 25.0 | 416 | 0.31 % | 25.8 % | 22.7 % | 2.00 |
| Brooks Laboratories Ltd | 324 Cr. | 110 | 203/95.6 | 159 | 33.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Bliss GVS Pharma Ltd | 1,770 Cr. | 167 | 191/105 | 16.2 | 99.7 | 0.30 % | 11.7 % | 8.36 % | 1.00 |
| Biofil Chemicals & Pharmaceuticals Ltd | 64.0 Cr. | 39.4 | 72.0/37.7 | 23.0 | 11.5 | 0.00 % | 4.12 % | 3.03 % | 10.0 |
| Biocon Ltd | 55,751 Cr. | 417 | 423/291 | 118 | 200 | 0.12 % | 6.25 % | 4.76 % | 5.00 |
| Beta Drugs Ltd | 1,691 Cr. | 1,675 | 2,190/1,430 | 37.4 | 219 | 0.00 % | 27.0 % | 25.9 % | 10.0 |
| Bal Pharma Ltd | 127 Cr. | 79.9 | 141/76.3 | 18.6 | 49.2 | 1.50 % | 10.1 % | 9.66 % | 10.0 |
| Bafna Pharmaceuticals Ltd | 437 Cr. | 185 | 205/67.8 | 41.4 | 38.6 | 0.00 % | 8.34 % | 7.69 % | 10.0 |
| Astrazeneca Pharma India Ltd | 22,958 Cr. | 9,183 | 10,691/6,220 | 99.3 | 320 | 0.35 % | 33.4 % | 23.6 % | 2.00 |
| Amrutanjan Health Care Ltd | 2,058 Cr. | 712 | 843/544 | 36.3 | 118 | 0.65 % | 22.4 % | 16.5 % | 1.00 |
| Alpa Laboratories Ltd | 180 Cr. | 85.3 | 137/79.7 | 6.81 | 86.4 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Alkem Laboratories Ltd | 68,457 Cr. | 5,726 | 5,868/4,492 | 29.1 | 1,116 | 0.79 % | 20.4 % | 19.4 % | 2.00 |
| Alembic Pharmaceuticals Ltd | 18,004 Cr. | 916 | 1,124/725 | 28.4 | 271 | 1.20 % | 13.0 % | 11.4 % | 2.00 |
| Albert David Ltd | 471 Cr. | 825 | 1,540/763 | | 690 | 0.61 % | 6.45 % | 4.39 % | 10.0 |
| Ajanta Pharma Ltd | 31,846 Cr. | 2,549 | 3,116/2,022 | 32.7 | 345 | 1.10 % | 32.4 % | 24.9 % | 2.00 |
| Advanced Enzyme Technologies Ltd | 3,821 Cr. | 341 | 412/258 | 25.9 | 133 | 1.52 % | 13.1 % | 9.54 % | 2.00 |
| Aarti Drugs Limited | 4,313 Cr. | 469 | 575/312 | 22.6 | 146 | 0.21 % | 13.5 % | 13.0 % | 10.0 |
| Industry Average | 20,232.29 Cr | 1,188.20 | | 55.64 | 201.40 | 0.34% | 16.24% | 14.95% | 6.10 |